10104 related articles for article (PubMed ID: 1589611)
21. [Prevention and early diagnosis of malignant melanoma].
Selvåg E; Loeb M; Larsen TE; Thune P
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2316-8. PubMed ID: 9691797
[TBL] [Abstract][Full Text] [Related]
22. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
23. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
24. [The primary cutaneous melanoma. Clinical aspects and histopathology, basis for prognosis].
Michalik EE
Fortschr Med; 1982 Jun; 100(22):1027-32. PubMed ID: 7106667
[TBL] [Abstract][Full Text] [Related]
25. [Statistical study of 623 cases of malignant cutaneous melanoma].
Maillard GF
Ann Dermatol Syphiligr (Paris); 1971; 98(1):5-20. PubMed ID: 4103132
[No Abstract] [Full Text] [Related]
26. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
27. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
29. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
30. [Course and therapy of malignant melanoma].
Storck H; Ott F
Schweiz Med Wochenschr; 1976 Dec; 106(51):1871-7. PubMed ID: 1013717
[TBL] [Abstract][Full Text] [Related]
31. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
Søndergaard K
Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
[TBL] [Abstract][Full Text] [Related]
32. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
[TBL] [Abstract][Full Text] [Related]
33. [Clinical and histopathological characteristics of malignant melanoma cases seen at "Dr. Manuel Gea González" General Hospital].
Káram-Orantes M; Toussaint-Caire S; Domínguez-Cherit J; Veja-Memije E
Gac Med Mex; 2008; 144(3):219-23. PubMed ID: 18714590
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma.
Brewer JD; Christenson LJ; Weenig RH; Weaver AL
Dermatol Surg; 2010 Mar; 36(3):368-76. PubMed ID: 20100262
[TBL] [Abstract][Full Text] [Related]
35. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
Golger A; Young DS; Ghazarian D; Neligan PC
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
[TBL] [Abstract][Full Text] [Related]
37. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
38. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
39. Thick melanoma: the problem continues.
Tejera-Vaquerizo A; Mendiola-Fernández M; Fernández-Orland A; Herrera-Ceballos E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):575-9. PubMed ID: 18081751
[TBL] [Abstract][Full Text] [Related]
40. Distribution of clinical-pathological types of cutaneous melanomas and mortality rate in the region of Passo Fundo, RS, Brazil.
Borges SZ; Bakos L; Cartell A; Wagner M; Agostini A; Lersch E
Int J Dermatol; 2007 Jul; 46(7):679-86. PubMed ID: 17614794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]